Source: Annual Congress 2003 - State of the art in assessing airway inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Efthimiadis, S. Chaibolliez, J. Milot, S. Ferreira, S. West, M. M. M. Pizzichini, E. Pizzichini, F. E. Hargreave (Hamilton, Canada). Induced sputum: standardisation of methods and cell counts in a multi-centre trial. Eur Respir J 2003; 22: Suppl. 45, 2646

Member's Comments

No comment yet.

Related content which might interest you: Asthma treatment based on sputum cell counts or usual clinical outcomes: the LOMA study Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003 Utility of BAL Galactomannan testing: A prospective analytical study Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Development of standardisation criteria for the measurement of lung clearance index in a multi-centre study Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007 The use of induced sputum in clinical trials Source: Eur Respir J 2002; 20: 47S-50S Year: 2002 Sample sizes for clinical trials using sputum eosinophils as a primary outcome Source: Eur Respir J 2013; 42: 1003-1011 Year: 2013 A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Sequential screening for lung cancer in a high-risk group: randomised controlled trial Source: Eur Respir J, 54 (4) 1900581; 10.1183/13993003.00581-2019 Year: 2019 The effect of azithromycin on sputum inflammatory markers in bronchiectasis – analysis of a randomized controlled trial Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 Biological quality control for spirometry in a multi-centred clinical trial Source: Annual Congress 2008 - Quality spirometry: the only spirometry! Year: 2008 Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design Source: Eur Respir J 2015; 45: 511-524 Year: 2015 Late Breaking Abstract - Effect on asthma control using a novel digital self-management system: a physician blinded randomised controlled cross-over pilot trial Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Minimising selection bias in cluster randomised controlled trials: Practical solutions Source: Annual Congress 2010 - From diagnosis to disease management in primary care Year: 2010 A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial Source: Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020 Year: 2021 Wet sputum as an objective outcome in a randomized crossover trial in NCF-BE: Reliability and responsiveness Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions Year: 2014 Cost-effectiveness comparison of three methods for differential cell count in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002 Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Evaluation of biological quality control variance in a multi-center clinical trial for inhaled insulin Source: Annual Congress 2007 - Quality, sleep and physiology Year: 2007 Evaluation of data requirements to establish biologic quality control ranges in a multi-center clinical trial for inhaled insulin Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future Year: 2008